MYCN and neoplasm: In an earlier study [11], we used SNP arrays to analyse tumours from patients who had received pre-operative chemotherapy under International Society of Paediatric Oncology (SIOP) protocols, and noted an apparent association between MYCN gain and the high risk diffuse anaplastic subtype.